Pmq Inga 15mg Tablet is classified as an antiparasitic medicine primarily used for the prevention and treatment of malaria, a disease caused by a plasmodium parasite transmitted through mosquito bites. The severity of malaria varies, with symptoms such as chills, fever, and sweating usually appearing a few weeks after being bitten. Individuals traveling to malaria-prone regions typically take protective drugs before, during, and after their trip to reduce the risk of contracting the disease.

The active ingredient in Pmq Inga 15mg Tablet is primaquine, which functions by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. By killing the parasites responsible for the infection, this medication effectively prevents the spread of malaria. Specifically, Pmq Inga 15mg Tablet is used to prevent relapses of malaria caused by Plasmodium vivax and Plasmodium ovale strains of the parasite.

It is essential to take Pmq Inga 15mg Tablet as directed by your doctor, preferably with a meal to minimize stomach upset, and at regular intervals daily for optimal efficacy. The prescribed dosage may vary depending on the individual's condition and the severity of the infection. Completing the full course of treatment before visiting malaria-prone areas is crucial to ensure maximum protection.

Potential side effects of Pmq Inga 15mg Tablet include rash, vomiting, headache, dizziness, hives, stomach pain, nausea, abdominal pain, itching, heartburn, and gastrointestinal discomfort. However, not everyone may experience these side effects. If any discomfort is experienced, it is advisable to stop the medication and consult with a healthcare provider.

Before initiating treatment with Pmq Inga 15mg Tablet, inform your doctor if you are allergic to the medication. It is important not to self-administer this medication and to use caution in pregnant or breastfeeding individuals. Pmq Inga 15mg Tablet is not recommended for patients with heart disease, liver problems, kidney issues, or rheumatoid arthritis, as it may pose risks to these individuals. Regular monitoring of blood cell counts may be required for long-term use, and individuals should promptly report any unusual symptoms such as unexplained bruising, bleeding, sore throat, fever, or fatigue to their healthcare provider.